Generation and Characterization of a Chimeric Rabbit/Human Fab for Co-Crystallization of HIV-1 Rev

Journal of Molecular Biology

Volumn 397, Issue 3, 2010, Pages 697-708

  Stahl, Stephen J ^a   Watts, Norman R ^a   Rader, Christoph ^b   DiMattia, Michael A ^a,c   Mage, Rose G ^d   Palmer, Ira ^a   Kaufman, Joshua D ^a   Grimes, Jonathan M ^c   Stuart, David I ^c   Steven, Alasdair C ^a   Wingfield, Paul T ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

crystallization chaperone; humanized Fab; phage display; rabbit antibody; scFv

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; REV PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTALLIZATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; RABBIT;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1; ORYCTOLAGUS CUNICULUS;

EID: 77649336166     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.01.061     Document Type: Article

References (39)

1. Mage R.G., Lanning D., and Knight K.L. B cell and antibody repertoire development in rabbits: the requirement of gut-associated lymphoid tissues. Dev. Comp. Immunol. 30 (2006) 137-153
2. Ridder R., Schmitz R., Legay F., and Gram H. Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris. Biotechnology (NY) 13 (1995) 255-260
3. Lang I.M., Barbas III C.F., and Schleef R.R. Recombinant rabbit Fab with binding activity to type-1 plasminogen activator inhibitor derived from a phage-display library against human alpha-granules. Gene 172 (1996) 295-298
4. Foti M., Granucci F., Ricciardi-Castagnoli P., Spreafico A., Ackermann M., and Suter M. Rabbit monoclonal Fab derived from a phage display library. J. Immunol. Methods 213 (1998) 201-212
5. Rader C., Ritter G., Nathan S., Elia M., Gout I., Jungbluth A.A., et al. The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies. J. Biol. Chem. 275 (2000) 13668-13676
6. Spieker-Polet H., Sethupathi P., Yam P.C., and Knight K.L. Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas. Proc. Natl Acad. Sci. USA 92 (1995) 9348-9352
7. Popkov M., Jendreyko N., Gonzalez-Sapienza G., Mage R.G., Rader C., and Barbas III C.F. Human/mouse cross-reactive anti-VEGF receptor 2 recombinant antibodies selected from an immune b9 allotype rabbit antibody library. J. Immunol. Methods 288 (2004) 149-164
8. Popkov M., Mage R.G., Alexander C.B., Thundivalappil S., Barbas III C.F., and Rader C. Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: the impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected by phage display. J. Mol. Biol. 325 (2003) 325-335
9. Hofer T., Tangkeangsirisin W., Kennedy M.G., Mage R.G., Raiker S.J., Venkatesh K., et al. Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector. J. Immunol. Methods 318 (2007) 75-87
10. Rader C. Antibody libraries in drug and target discovery. Drug Discov. Today 6 (2001) 36-43
11. Rader C. Generation and selection of rabbit antibody libraries by phage display. Methods Mol. Biol. 525 (2009) 101-128
12. Steinberger P., Sutton J.K., Rader C., Elia M., and Barbas III C.F. Generation and characterization of a recombinant human CCR5-specific antibody. A phage display approach for rabbit antibody humanization. J. Biol. Chem. 275 (2000) 36073-36078
13. Rader C., and Barbas III C.F. Phage display of combinatorial antibody libraries. Curr. Opin. Biotechnol. 8 (1997) 503-508
14. Hoogenboom H.R. Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 23 (2005) 1105-1116
15. Rader C. Overview on concepts and applications of Fab antibody fragments. Curr. Protoc. Protein Sci. (2009) Chapter 6, Unit 6.9
16. Ye J.D., Tereshko V., Frederiksen J.K., Koide A., Fellouse F.A., Sidhu S.S., et al. Synthetic antibodies for specific recognition and crystallization of structured RNA. Proc. Natl Acad. Sci. USA 105 (2008) 82-87
17. Zhou Y., Morais-Cabral J.H., Kaufman A., and MacKinnon R. Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 A resolution. Nature 414 (2001) 43-48
18. Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450 (2007) 383-387
19. Uysal S., Vasquez V., Tereshko V., Esaki K., Fellouse F.A., Sidhu S.S., et al. Crystal structure of full-length KcsA in its closed conformation. Proc. Natl Acad. Sci. USA 106 (2009) 6644-6649
20. Groom H.C., Anderson E.C., and Lever A.M. Rev: beyond nuclear export. J. Gen. Virol. 90 (2009) 1303-1318
21. Watts N.R., Misra M., Wingfield P.T., Stahl S.J., Cheng N., Trus B.L., et al. Three-dimensional structure of HIV-1 Rev protein filaments. J. Struct. Biol. 121 (1998) 41-52
22. Wingfield P.T., Stahl S.J., Payton M.A., Venkatesan S., Misra M., and Steven A.C. HIV-1 Rev expressed in recombinant Escherichia coli: purification, polymerization, and conformational properties. Biochemistry 30 (1991) 7527-7534
23. Kwong K.Y., and Rader C. E. coli expression and purification of Fab antibody fragments. Curr. Protoc. Protein Sci. (2009) Chapter 6, Unit 6.10
24. Drake A.W., Myszka D.G., and Klakamp S.L. Characterizing high-affinity antigen/antibody complexes by kinetic- and equilibrium-based methods. Anal. Biochem. 328 (2004) 35-43
25. Cole J.L., Gehman J.D., Shafer J.A., and Kuo L.C. Solution oligomerization of the rev protein of HIV-1: implications for function. Biochemistry 32 (1993) 11769-11775
26. Philo J.S. A method for directly fitting the time derivative of sedimentation velocity data and an alternative algorithm for calculating sedimentation coefficient distribution functions. Anal. Biochem. 279 (2000) 151-163
27. Borgstahl G.E. How to use dynamic light scattering to improve the likelihood of growing macromolecular crystals. Methods Mol. Biol. 363 (2007) 109-129
28. DiMattia, M. A., Watts, N. R., Stahl, S. J., Rader, C., Wingfield, P. T., Stuart, D. I. et al. (2010). Implications of the HIV-1 Rev dimer structure at 3.2 Å resolution for multimeric binding to the Rev response element. Proc. Natl. Acad. Sci. USA, doi:10.1073/pnas.0914946107.
29. Ditzel H.J., Binley J.M., Moore J.P., Sodroski J., Sullivan N., Sawyer L.S., et al. Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure. J. Immunol. 154 (1995) 893-906
30. Hunte C., and Michel H. Crystallisation of membrane proteins mediated by antibody fragments. Curr. Opin. Struct. Biol. 12 (2002) 503-508
31. Jain C., and Belasco J.G. Structural model for the cooperative assembly of HIV-1 Rev multimers on the RRE as deduced from analysis of assembly-defective mutants. Mol. Cell 7 (2001) 603-614
32. Pond S.J., Ridgeway W.K., Robertson R., Wang J., and Millar D.P. HIV-1 Rev protein assembles on viral RNA one molecule at a time. Proc. Natl Acad. Sci. USA 106 (2009) 1404-1408
33. Pallesen J., Dong M., Besenbacher F., and Kjems J. Structure of the HIV-1 Rev response element alone and in complex with regulator of virion (Rev) studied by atomic force microscopy. FEBS J. 276 (2009) 4223-4232
34. Rondon I.J., and Marasco W.A. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annu. Rev. Microbiol. 51 (1997) 257-283
35. Wu Y., Duan L., Zhu M., Hu B., Kubota S., Bagasra O., and Pomerantz R.J. Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition. J. Virol. 70 (1996) 3290-3297
36. Arkin M.R., and Wells J.A. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat. Rev., Drug Discov. 3 (2004) 301-317
37. Beckett D., Kovaleva E., and Schatz P.J. A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation. Protein Sci. 8 (1999) 921-929
38. Cohn E.J., and Edsall T. Proteins, Amino Acids and Peptides (1943), Van-Nostrand-Reinhold, Princeton, NJ
39. Stenberg E., Persson B., Roos H., and Urbaniczky C. Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins. J. Colloid Interface Sci. 143 (1991) 513-526